Nanobiotix | Mutual Funds
Mutual Funds that own Nanobiotix
AXA Framlington Biotech Fund
307,677
1.57%
307,677
0.89%
02/28/2018
JPMorgan Funds - Global Healthcare Fund
301,307
1.54%
0
0.21%
05/31/2018
Government Pension Fund - Global (The)
207,173
1.06%
-1
0%
12/31/2017
Stichting Pensioenfonds ABP (Global Equity Portfolio)
157,853
0.8%
-18,203
0%
03/31/2018
Aviva France Opportunités
145,886
0.74%
0
1.59%
08/31/2018
AXA World Funds - Framlington Europe Micro Cap
114,000
0.57%
114,000
0.8%
12/31/2017
HSBC Small Cap France
110,012
0.56%
-2,488
0.7%
12/29/2017
100,000
0.51%
100,000
1.06%
06/30/2017
Natixis Actions Euro Micro Caps
80,000
0.41%
0
1.27%
06/29/2018
Amilton Small Caps
48,447
0.25%
48,447
1.01%
06/30/2017
| Address |
60, rue de Wattignies
Paris Ile-de-France 75012
France
|
|
Employees
|
- |
| Website |
http://www.nanobiotix.com |
| Updated |
07/08/2019 |
| Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer. |
